Comparative Human Factors Studies are required for ANDA submissions in the USA where a generic product must demonstrate equivalence in use to the reference device.

We design and conduct comparative studies supported by Threshold Analysis, risk assessment and statistical sample size determination. Testing focuses on demonstrating that any design differences do not introduce new or increased use-related risks.

The result is a structured, regulatory-ready study package aligned with FDA expectations for generic product approval.